KIDNEY DIALYSIS EQUIPMENT MARKET ANALYSIS

Market Size and Trends

Global kidney dialysis equipment market is estimated to be valued at USD 21.41 Bn in 2024 and is expected to reach USD 30.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5% from 2024 to 2031. Rising prevalence of end-stage renal diseases across the globe can drive the market growth.

To learn more about this report, request a free sample copy

Global kidney dialysis equipment market is expected to witness a steady growth over the forecast period, owing to increasing incidences of chronic kidney diseases. Factors such as growing geriatric population, rising cases of diabetes and hypertension, technological advancements in dialysis equipment and growing awareness about kidney disease treatment and management can boost adoption of kidney dialysis equipment. Furthermore, favorable reimbursement policies for dialysis procedures in developed nations and launch of innovative products by market players can drive the market growth over the forecast period.

Rising Prevalence of Chronic Kidney Diseases

Global kidney dialysis equipment market growth is driven by rising prevalence of chronic kidney diseases across the globe. Kidney diseases have become one of the major causes of mortality and poses a huge burden on healthcare systems worldwide. Various chronic conditions like diabetes, hypertension, glomerulonephritis contribute to rising incidence of kidney failure. According to the data published by WHO, chronic kidney diseases affected around 1.2 million people globally in 2020 and the number is estimated to increase substantially in the near future. Rising geriatric population  also increases incidence of chronic kidney diseases with age being a significant risk factor. Moreover, growing prevalence of an unhealthy lifestyle characterized by poor diet, lack of physical exercise, rising stress levels and increased consumption of alcohol and tobacco products has further aggravated the risk of kidney ailments. Increase in risk factors is anticipated to trigger higher cases of end-stage renal disease (ESRD) that warrants renal replacement therapies like kidney dialysis, kidney transplantation for survival. Improving access to diagnosis and availability of dialysis services in developing regions enables more patients to receive life-saving renal replacement treatments. Rising cases of chronic kidney diseases and ESRD patients depending on dialysis procedures have significantly boosted demand for kidney dialysis equipment. For instance, in October 2021, according to a study published by Frontiers in Public Health, urinary tract infections (UTIs) led to approximately 7 million outpatient visits, 1 million emergency outpatient visits, and 100,000 hospitalizations annually among the elderly, comprising about 25% of all infectious diseases in this age group. In April 2022, according to a study published by Kidney International Supplements, chronic kidney disease affects over 10% of the global population, totaling more than 800 million individuals.

Market Concentration and Competitive Landscape

To learn more about this report, request a free sample copy

Technological Innovations and Product Advancements

Technological innovations and product advancements can drive the global kidney dialysis equipment market growth. Kidney failure patients require long-term dialysis treatment to filter waste and excess fluid from their blood, and this treatment requires advanced dialysis machines and related products. Over the past few years, key market players have invested heavily in research and development to introduce next-generation equipment with improved functionalities. For example, major manufacturers are focusing on developing portable and home hemodialysis devices with improved usability. These new compact systems allow patients to receive treatment outside of dialysis clinics, offering greater flexibility and improving their quality of life. Various innovations such as easy-to-use tubing and automated settings have made home hemodialysis systems patient-friendly. According to the data published by the United States Renal Data System, home hemodialysis treatments in the U.S. had increased from 2,345 patients in 2015 to 5,363 patients in 2020. Manufacturers are utilizing artificial intelligence and digital technologies to make dialysis therapy more customized and effective. Some new products analyze treatment data to help clinicians finely tune the process for each individual. Sensors embedded in dialyzers and bloodlines now enable real-time monitoring of various parameters.

Key Takeaways from Analyst

Global kidney dialysis equipment market growth is driven by rising prevalence of chronic kidney diseases and end-stage renal diseases. Increasing geriatric population who are more prone to develop kidney problems can also boost demand for dialysis equipment and services. Moreover, large pool of baby boomers entering their retirement years can also drive the market growth.

High costs associated with dialysis treatment and equipment can hamper the market growth. Dialysis procedures and equipment are significantly expensive that can limit its widespread adoption, especially in developing regions with budget constraints. Reimbursement policies also vary largely across countries, thus, posing reimbursement challenges.

North America dominates the global dialysis equipment market, owing to advanced healthcare infrastructure and increasing healthcare spending. Factors such as rising healthcare awareness and disposable incomes can also drive the market growth in the region. Asia Pacific region is expected to witness the fastest growth over the forecast period due to improving access to healthcare facilities, growing medical tourism, and rising focus of leading global players on expanding in emerging Asian countries. Further advancements in dialysis modalities like home hemodialysis can offer market growth opportunities.

Market Challenges: High costs associated with dialysis treatments and equipment

High costs associated with kidney dialysis treatments and equipment can hamper the global kidney dialysis equipment market growth. Dialysis treatment is a lifelong requirement for patients with end-stage kidney disease and puts a huge financial burden on both patients and healthcare systems. Dialysis equipment like dialysis machines, bloodline sets, and dialyzers have high acquisition and maintenance costs. A dialysis machine can cost anywhere between US$ 25,000 to US$ 50,000 and requires periodic replacement after 5-7 years of use. Disposable dialysis consumables like dialyzers need to be replaced for every treatment, which is usually conducted 3 times a week. This leads to significant recurring costs. Dialysis centers require substantial infrastructure and manpower for round the clock operations, thus, increasing operational expenses.

The financial burden of dialysis falls disproportionately on low- and middle-income patients who have limited or no health insurance coverage. According to the data published by WHO, over 80% of the global dialysis patients are from low- and middle-income countries where most people cannot afford dialysis therapy through private payment. Public healthcare budgets in these countries are often not enough to provide universal access to dialysis therapy.

Market Opportunities: Strategic collaborations, partnerships and mergers & acquisitions

Strategic collaborations, partnerships and mergers & acquisitions can offer significant opportunities for global kidney dialysis equipment market growth. Rising kidney diseases and kidney failure due to increasing risk factors like diabetes, obesity, and hypertension can boost demand for effective dialysis treatment options. However, setting up dialysis centers and expanding access to therapy requires large investments of capital and resources. By leveraging strengths and expertise through collaborations, companies in the kidney dialysis equipment market can develop and deliver more comprehensive and affordable care solutions to a greater number of patients globally. For example, partnerships between medical device firms and dialysis service providers allow for more optimized systems that lower costs and improve outcomes. Equipment manufacturers teaming up with independent research bodies can also help in designing innovative products catered to the local needs of underserved regions.

To learn more about this report, request a free sample copy

By Product Type: Dominance of Hemodialysis Equipment

In terms of product type, hemodialysis equipment segment is estimated to contribute the highest market share of 45% in 2024, owing to its widespread use and effectiveness. Hemodialysis equipment allows blood to be pumped out of the body to an artificial kidney machine for filtration before being returned, which removes toxins and extra fluids when the kidneys are unable to perform these functions naturally. Hemodialysis treatment is the most commonly prescribed renal replacement therapy for end-stage kidney disease patients. It is often preferred over peritoneal dialysis as it is viewed as a more flexible treatment option that does not restrict lifestyle or diet. Hemodialysis can also effectively clear more waste from the blood than peritoneal dialysis, making it suitable for patients with more severe kidney failure. Advances in hemodialysis equipment technology have also improved treatment outcomes and quality of life for patients. Growing prevalence of chronic kidney disease and end-stage renal disease boosts  demand for hemodialysis equipment. Aging population further increases the burden of kidney disease. More frequent hemodialysis treatments are also being used to improve clinical outcomes for patients. Hospital-based hemodialysis remains the standard of care due to equipment costs and specialized staff required. However, home hemodialysis is gaining popularity as it allows patients greater independence and flexibility while avoiding facility-based care. New portable hemodialysis machines aim to make home therapy easier by reducing the physical space and supplies needed.

By End User: Hospitals & Clinics: Cornerstone of Kidney Dialysis Treatment

Among the end user, hospitals & clinics segment is estimated to contribute the highest market share of 40.2% in 2024. Most patients rely on hospital- or clinic-based outpatient hemodialysis to manage their kidney disease. Hospitals and specialized dialysis clinics have developed the expertise, infrastructure, and economies of scale to offer efficient hemodialysis treatment programs. The large patient volumes support the high capital investments in advanced dialysis machines, water purification systems, and other equipment needed. Specialized renal teams in these facilities also help ensure optimal clinical outcomes.

In many countries, hospitals and public health systems play a major role in financing and providing dialysis access. This public funding address the high treatment costs of kidney replacement therapy that would otherwise limit access. Even as home dialysis and dialysis centers have expanded, facilities remain integral to kidney care through inpatient dialysis and as referral centers for complex patients. Hospitals also offer peritoneal dialysis training programs as more patients choose this home-based option. Outreach programs help transition appropriate patients from facility-based to home-based care when clinically indicated.

Regional Insights

To learn more about this report, request a free sample copy

North America dominates the global kidney dialysis equipment market with an estimated market share of 38.2% in 2024. This region is home to several top pharmaceutical companies who outsource a major portion of their preclinical research activities. With strong presence of CROs catering to the life sciences industry and high investments in R&D, North America provides ideal conditions for the market growth. The region also has stringent regulations for product testing and development which boosts demand for specialized preclinical services. Several global players have established their headquarters and major facilities in the U.S. and Canada to leverage the skilled workforce and expertise available. This has ensured that North America remains the primary export and import hub for kidney dialysis equipment internationally.

Asia Pacific region is poised to be the fastest growing market in the near future. Countries like China, India, and South Korea offer lower operational costs as compared to mature markets, attracting several pharmaceutical giants to outsource their preclinical work to Asia Pacific. This has encouraged local and international CROs to expand their footprint in the region to capture a share of the outsourced business. The economic development of Asia Pacific countries has also led to greater healthcare investments and a focus on developing domestic life sciences capabilities. This boosts demand for specialized in vivo services to support drug development programs within the region. With growing expertise, a large talent pool and proximity to resource-rich nations, asia pacific is well positioned to take over as the dominant outsourcing destination for global kidney dialysis equipment requirements.

Market Report Scope

Key Developments

• In February 2024, Fresenius Medical Care (FME), a global company in products and services for individuals with renal diseases, announced FDA 510(k) clearance for its 5008X Hemodialysis System. This clearance marks a pivotal step towards setting a new standard of care in dialysis therapy for people with kidney diseases in the U.S.
• In March 2022, Nipro Medical Corporation, Medical equipment manufacturer introduced the SURDIAL DX Hemodialysis System to the United States, expanding its range of renal, vascular, and medical-surgical products.
• In August 2023, Quanta Dialysis Technologies obtained USFDA clearance to expand the indication of its Quanta Dialysis System. This clearance permits the system to be utilized for dialysis treatment in patients diagnosed with acute kidney issues.
• In March 2021, three dialysis machines were installed at the TANKER Foundation's, a registered non-profit charitable trust facility in Thiruverkadu, Ambattur, and Nungambakkam.
• In April 2020, the U.S. Food and Drug Administration authorized a new device for continuous hemodialysis or hemofiltration therapy in critically ill pediatric patients weighing between 2.5 and 10 kilograms (5.5 to 22 pounds). Known as continuous renal replacement therapy (CRRT), this treatment uses a dialysis machine and special filter to continuously cleanse blood without the traditional three-times-weekly sessions.

*Definition: Kidney Dialysis Equipment market consists of pharmaceutical drugs that are used to treat kidney cancer. The market includes drugs from different drug classes that are used to target different molecular pathways involved in the development and progression of kidney cancers. Some of the major drug classes included in this market are targeted therapies such as tyrosine kinase inhibitors, mTOR inhibitors, angiogenesis inhibitors; immunotherapies such as checkpoint inhibitors; and chemotherapies.

Market Segmentation

•  Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Hemodialysis Equipment
  • Peritoneal Dialysis Equipment
  • Continuous Renal Replacement Therapy (CRRT)
  • Concentrates and Solutions
  • Catheters and Tubings
  • Other Products
•  End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals & Clinics
  • Dialysis Centers
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Fresenius Medical Care AG & Co. KGaA
  • Baxter International Inc.
  • Davita Inc.
  • B. Braun Melsungen AG
  • Asahi Kasei Corporation
  • Nipro Corporation
  • Cantel Medical Corporation
  • Nikkiso Co., Ltd.
  • Medical Care AG & Co. KGaA
  • Diaverum Deutschland GmbH
  • Medtronic PLC
  • Toray Medical Co., Ltd.
  • Allmed Medical Corp.
  • Bain Medical Equipment
  • JMS Co. Ltd.
  • HEMOCLEAN CO., LTD.
  • Rockwell Medical